# Peer Review Report: Research Synthesis Methods (RSM)
**Manuscript ID:** RSM-2026-0458
**Title:** The "Evidence Integrity" Suite: A Systematic Pipeline for Detecting Bias and Premature Conclusions in Health Technology Assessment
**Recommendation:** **Major Revision**

---

## 📝 Associate Editor’s Comments
This manuscript addresses two of the most persistent challenges in research synthesis: publication bias and the "Information Size Crisis." The integration of these into a unified HTA validation pipeline is ambitious and highly relevant to the RSM readership. However, for a methodological journal, several statistical choices require more rigorous justification and potential sensitivity analyses.

---

## 👤 Reviewer #1: Senior Statistical Methodologist
**Expertise:** Bias Correction Models, Power Analysis in Meta-Analysis

### 1. Statistical Rigor & Assumptions
*   **Trim-and-Fill Estimators:** The authors use the "R0" estimator for Trim-and-Fill. While standard, recent literature suggests that "L0" or "Q0" estimators may be more robust in specific scenarios. Can the authors provide a rationale for selecting R0 or provide a sensitivity check using a selection-based model (e.g., Copas or PET-PEESE)?
*   **Dynamic OIS Derivation:** I commend the authors for implementing a dynamic diversity factor ($1/(1-I^2)$). This is a significant improvement over static models. However, the authors must clarify if the variance used in the OIS calculation ($D$) is based on the fixed-effect or random-effects assumption. In HTA, the random-effects OIS is the true requirement.
*   **Egger's Test Power:** With a sample of $k \ge 3$, Egger’s test is notoriously underpowered. The authors must discuss the "False Negative" rate of bias detection in their small-k meta-analyses and how this affects the "Gold Standard" classification.

### 2. Recommendation
**Major Revision.** The pipeline is excellent, but the statistical foundation needs a deeper "Stress Test" before RSM can endorse it as a standard.

---

## 👤 Reviewer #2: Meta-Epidemiologist
**Expertise:** Cochrane Methodology, Evidence Mapping, Large-scale Data Mining

### 1. Dataset Validity (Pairwise70)
*   **Selection Bias:** The Pairwise70 dataset is derived from Cochrane reviews. While these are high quality, they are often more rigorous than the "de novo" meta-analyses performed by HTA agencies. The authors should discuss whether their findings (8.6% Gold Standard) might actually be an *optimistic* estimate compared to non-Cochrane HTA evidence.
*   **Outcome Heterogeneity:** The "Evidence Decay" model shows high AUC, but does it account for the *type* of outcome? Subjective outcomes (e.g., pain scales) are often more prone to decay than objective ones (e.g., mortality). Adding "Outcome Type" as a feature in the Logistic Regression would strengthen the ML component.

### 2. Recommendation
**Minor Revision.** The data is impressive, but more context on the generalizability beyond Cochrane is needed.

---

## 👤 Reviewer #3: HTA Policy & GRADE Expert
**Expertise:** Guideline Development, GRADE Framework, Decision Analysis

### 1. Integration with Existing Frameworks
*   **Alignment with GRADE:** How does the "Evidence Integrity Suite" map to the GRADE "Inconsistency" and "Publication Bias" domains? The authors should provide a table showing how their "Evidence Classes" (Gold, Robust, Premature) should influence the *Certainty of Evidence* ratings. 
*   **Actionability:** The "Premature" category is the most valuable for HTA. I suggest the authors develop a "Decision Rule" for this category—e.g., should HTA bodies grant "Conditional Reimbursement with Evidence Generation" (managed access) for all Premature findings?

### 2. Recommendation
**Accept with Major Revisions.** The bridge between the statistics and the HTA policy needs to be strengthened.

---

## 📋 Summary of Required Revisions

1.  **Sensitivity Analysis (Bias):** Compare Trim-and-Fill results with at least one other correction method (e.g., PET-PEESE) for the "High Risk" cases.
2.  **ML Feature Expansion:** Include "Outcome Type" (Binary vs. Continuous) and "Objective vs. Subjective" as features in the decay prediction model.
3.  **GRADE Mapping:** Provide a formal mapping of the Evidence Integrity Suite to the GRADE framework.
4.  **OIS Transparency:** Explicitly state the variance assumptions used in the OIS formula in the Methods section.

---

**Final Verdict:** This paper has the potential to be a high-impact "Methods Paper" in RSM, provided the authors address the statistical nuances of bias correction and the practical alignment with HTA decision-making frameworks.
